BDBM362300 5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 115

SMILES Cc1cnn(Cc2ccc(Cn3ncc(C(=O)NCc4c(C)cc(CN)cc4C)c3C)cc2)c1

InChI Key InChIKey=FKHUEKYDJMRASN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 362300   

TargetKallikrein-1(Homo sapiens (Human))
Kalvista Pharmceuticals

US Patent
LigandPNGBDBM362300(5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl...)
Affinity DataIC50: >1.00E+4nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
Kalvista Pharmceuticals

US Patent
LigandPNGBDBM362300(5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl...)
Affinity DataIC50:  8nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent